{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T06:51:48Z","timestamp":1769151108180,"version":"3.49.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T00:00:00Z","timestamp":1546646400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572332"],"award-info":[{"award-number":["81572332"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81201936"],"award-info":[{"award-number":["81201936"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572358"],"award-info":[{"award-number":["81572358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s10147-018-1377-1","type":"journal-article","created":{"date-parts":[[2019,1,5]],"date-time":"2019-01-05T15:50:21Z","timestamp":1546703421000},"page":"141-152","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical significance of multiple gene detection with a 22-gene panel in formalin-fixed paraffin-embedded specimens of 207 colorectal cancer patients"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8020-6946","authenticated-orcid":false,"given":"Xian Hua","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guan Yu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong Gang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanumant","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lian Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen Guang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,5]]},"reference":[{"key":"1377_CR1","volume-title":"World Cancer Report 2014","year":"2014","unstructured":"Stewart B, Wild CP (eds) (2014) World Cancer Report 2014. International Agency for Research on Cancer (IARC), Lyon"},{"issue":"1","key":"1377_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ijms18010197","volume":"18","author":"I Marmol","year":"2017","unstructured":"Marmol I, Sanchez-de-Diego C, Pradilla Dieste A et al (2017) Colorectal carcinoma: a general overview and future perspectives in colorectal cancer. Int J Mol Sci 18(1):197","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1377_CR3","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1093\/annonc\/mdx052","volume":"28","author":"R Dienstmann","year":"2017","unstructured":"Dienstmann R, Mason MJ, Sinicrope FA et al (2017) Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study. Ann Oncol 28(5):1023\u20131031","journal-title":"Ann Oncol"},{"issue":"3","key":"1377_CR4","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/jcb.24401","volume":"114","author":"N Normanno","year":"2013","unstructured":"Normanno N, Rachiglio AM, Roma C et al (2013) Molecular diagnostics and personalized medicine in oncology: challenges and opportunities. J Cell Biochem 114(3):514\u2013524","journal-title":"J Cell Biochem"},{"issue":"3","key":"1377_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/mco.2017.1149","volume":"6","author":"J Garde Noguera","year":"2017","unstructured":"Garde Noguera J, Jantus-Lewintre E, Gil-Raga M et al (2017) Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first-line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: a retrospective analysis. Mol Clin Oncol 6(3):403\u2013408","journal-title":"Mol Clin Oncol"},{"key":"1377_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12885-015-1015-5","volume":"15","author":"BB Tops","year":"2015","unstructured":"Tops BB, Normanno N, Kurth H et al (2015) Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the Onconetwork consortium. BMC Cancer 15:26","journal-title":"BMC Cancer"},{"key":"1377_CR7","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jmoldx.2017.04.005","volume":"19","author":"JM Rey","year":"2017","unstructured":"Rey JM, Ducros V, Pujol P et al (2017) Improving mutation screening in patients with colorectal cancer predisposition using next-generation sequencing. J Mol Diagn 19:589\u2013601","journal-title":"J Mol Diagn"},{"issue":"3","key":"1377_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00428-015-1789-5","volume":"467","author":"JR Dijkstra","year":"2015","unstructured":"Dijkstra JR, Tops BB, Nagtegaal ID et al (2015) The homogeneous mutation status of a 22 gene panel justifies the use of serial sections of colorectal cancer tissue for external quality assessment. Virchows Arch 467(3):273\u2013278","journal-title":"Virchows Arch"},{"issue":"2","key":"1377_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jmoldx.2012.11.006","volume":"15","author":"AG Hadd","year":"2013","unstructured":"Hadd AG, Houghton J, Choudhary A et al (2013) Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens. J Mol Diagn 15(2):234\u2013247","journal-title":"J Mol Diagn"},{"key":"1377_CR10","doi-asserted-by":"publisher","first-page":"18678","DOI":"10.1038\/srep18678","volume":"5","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zheng J, Yang Y et al (2015) Molecular spectrum of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese colorectal cancer patients: analysis of 1,110 cases. Sci Rep 5:18678","journal-title":"Sci Rep"},{"issue":"2","key":"1377_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/sj.bjc.6601894","volume":"91","author":"S Bamford","year":"2004","unstructured":"Bamford S, Dawson E, Forbes S et al (2004) The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 91(2):355\u2013358","journal-title":"Br J Cancer"},{"issue":"7152","key":"1377_CR12","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature05933","volume":"448","author":"JD Carpten","year":"2007","unstructured":"Carpten JD, Faber AL, Horn C et al (2007) A transforming mutation in the pleckstrin homology domain of AKT1 in cancer. Nature 448(7152):439\u2013444","journal-title":"Nature"},{"issue":"4","key":"1377_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/gutjnl-2012-302423","volume":"62","author":"S Tian","year":"2013","unstructured":"Tian S, Simon I, Moreno V et al (2013) A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction. Gut 62(4):540\u2013549","journal-title":"Gut"},{"issue":"1","key":"1377_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1158\/2159-8274.CD-11-0005","volume":"1","author":"PS Hammerman","year":"2011","unstructured":"Hammerman PS, Sos ML, Ramos AH et al (2011) Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discov 1(1):78\u201389","journal-title":"Cancer Discov"},{"issue":"18","key":"1377_CR15","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1158\/1078-0432.CCR-12-0912","volume":"18","author":"ME Arcila","year":"2012","unstructured":"Arcila ME, Chaft JE, Nafa K et al (2012) Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas. Clin Cancer Res 18(18):4910\u20134918","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1377_CR16","doi-asserted-by":"publisher","first-page":"882","DOI":"10.21037\/jgo.2016.11.02","volume":"7","author":"HO Al-Shamsi","year":"2016","unstructured":"Al-Shamsi HO, Jones J, Fahmawi Y et al (2016) Molecular spectrum of KRAS, NRAS, BRAF, PIK3CA, TP53, and APC somatic gene mutations in Arab patients with colorectal cancer: determination of frequency and distribution pattern. J Gastrointest Oncol 7(6):882\u2013902","journal-title":"J Gastrointest Oncol"},{"issue":"2","key":"1377_CR17","doi-asserted-by":"publisher","first-page":"101042831769226","DOI":"10.1177\/1010428317692265","volume":"39","author":"M Jauhri","year":"2017","unstructured":"Jauhri M, Bhatnagar A, Gupta S et al (2017) Prevalence and coexistence of KRAS, BRAF, PIK3CA, NRAS, TP53, and APC mutations in Indian colorectal cancer patients: next-generation sequencing-based cohort study. Tumour Biol 39(2):1010428317692265","journal-title":"Tumour Biol"},{"issue":"12","key":"1377_CR18","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1159\/000356814","volume":"36","author":"YS Chang","year":"2013","unstructured":"Chang YS, Chang SJ, Yeh KT et al (2013) RAS, BRAF, and TP53 gene mutations in Taiwanese colorectal cancer patients. Onkologie 36(12):719\u2013724","journal-title":"Onkologie"},{"issue":"10","key":"1377_CR19","doi-asserted-by":"publisher","first-page":"12153","DOI":"10.3390\/ijms131012153","volume":"13","author":"AK Arrington","year":"2012","unstructured":"Arrington AK, Heinrich EL, Lee W et al (2012) Prognostic and predictive roles of KRAS mutation in colorectal cancer. Int J Mol Sci 13(10):12153\u201312168","journal-title":"Int J Mol Sci"},{"key":"1377_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1750-2187-6-2","volume":"6","author":"A Naguib","year":"2011","unstructured":"Naguib A, Wilson CH, Adams DJ et al (2011) Activation of K-RAS by co-mutation of codons 19 and 20 is transforming. J Mol Signal 6:2","journal-title":"J Mol Signal"},{"issue":"3","key":"1377_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/ijc.30089","volume":"139","author":"IM Loes","year":"2016","unstructured":"Loes IM, Immervoll H, Sorbye H et al (2016) Impact of KRAS, BRAF, PIK3CA, TP53 status and intraindividual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases. Int J Cancer 139(3):647\u2013656","journal-title":"Int J Cancer"},{"issue":"5","key":"1377_CR22","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1177\/1758834015591952","volume":"7","author":"NH Tran","year":"2015","unstructured":"Tran NH, Cavalcante LL, Lubner SJ et al (2015) Precision medicine in colorectal cancer: the molecular profile alters treatment strategies. Ther Adv Med Oncol 7(5):252\u2013262","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"1377_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12885-017-3381-7","volume":"17","author":"DD Won","year":"2017","unstructured":"Won DD, Lee JI, Lee IK et al (2017) The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients. BMC Cancer 17(1):403","journal-title":"BMC Cancer"},{"issue":"3","key":"1377_CR24","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1200\/JCO.2009.23.3452","volume":"28","author":"AD Roth","year":"2010","unstructured":"Roth AD, Tejpar S, Delorenzi M et al (2010) Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60 \u2013 00 trial. J Clin Oncol 28(3):466\u2013474","journal-title":"J Clin Oncol"},{"issue":"10","key":"1377_CR25","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1200\/JCO.2010.30.1366","volume":"29","author":"G Hutchins","year":"2011","unstructured":"Hutchins G, Southward K, Handley K et al (2011) Value of mismatch repair, KRAS, and BRAF mutations in predicting recurrence and benefits from chemotherapy in colorectal cancer. J Clin Oncol 29(10):1261\u20131270","journal-title":"J Clin Oncol"},{"issue":"4","key":"1377_CR26","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jamaoncol.2016.5469","volume":"3","author":"FA Sinicrope","year":"2017","unstructured":"Sinicrope FA, Shi Q, Allegra CJ et al (2017) Association of DNA mismatch repair and mutations in BRAF and kras with survival after recurrence in stage III colon cancers: a secondary analysis of 2 randomized clinical trials. JAMA Oncol 3(4):472\u2013480","journal-title":"JAMA Oncol"},{"issue":"1","key":"1377_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12885-016-2994-6","volume":"17","author":"I Nakayama","year":"2017","unstructured":"Nakayama I, Shinozaki E, Matsushima T et al (2017) Retrospective study of RAS\/PIK3CA\/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients. BMC Cancer 17(1):38","journal-title":"BMC Cancer"},{"issue":"42","key":"1377_CR28","doi-asserted-by":"publisher","first-page":"5648","DOI":"10.1038\/onc.2008.170","volume":"27","author":"FE Bleeker","year":"2008","unstructured":"Bleeker FE, Felicioni L, Buttitta F et al (2008) AKT1(E17K) in human solid tumours. Oncogene 27(42):5648\u20135650","journal-title":"Oncogene"},{"issue":"1","key":"1377_CR29","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2016.3771","volume":"50","author":"S Haggblad Sahlberg","year":"2017","unstructured":"Haggblad Sahlberg S, Mortensen AC, Haglof J et al (2017) Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells. Int J Oncol 50(1):5\u201314","journal-title":"Int J Oncol"},{"issue":"4","key":"1377_CR30","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2217\/fon.14.279","volume":"11","author":"L Foltran","year":"2015","unstructured":"Foltran L, De Maglio G, Pella N et al (2015) Prognostic role of KRAS, NRAS, BRAF and PIK3CA mutations in advanced colorectal cancer. Future Oncol 11(4):629\u2013640","journal-title":"Future Oncol"},{"issue":"15","key":"1377_CR31","doi-asserted-by":"crossref","first-page":"24892","DOI":"10.18632\/oncotarget.15279","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Yang Z, Tian H et al (2017) Circulating MIC-1\/GDF15 is a complementary screening biomarker with CEA and correlates with liver metastasis and poor survival in colorectal cancer. Oncotarget 8(15):24892\u201324901","journal-title":"Oncotarget"},{"issue":"8","key":"1377_CR32","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1002\/ijc.26182","volume":"130","author":"L Ohlsson","year":"2012","unstructured":"Ohlsson L, Israelsson A, Oberg A et al (2012) Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. Int J Cancer 130(8):1833\u20131843","journal-title":"Int J Cancer"},{"issue":"4","key":"1377_CR33","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.jmoldx.2017.04.005","volume":"19","author":"JM Rey","year":"2017","unstructured":"Rey JM, Ducros V, Pujol P et al (2017) Improving mutation screening in patients with colorectal cancer predisposition using next-generation sequencing. J Mol Diagn 19(4):589\u2013601","journal-title":"J Mol Diagn"},{"issue":"8","key":"1377_CR34","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/sj.onc.1208304","volume":"24","author":"JW Lee","year":"2005","unstructured":"Lee JW, Soung YH, Kim SY et al (2005) PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24(8):1477\u20131480","journal-title":"Oncogene"},{"issue":"1","key":"1377_CR35","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/bcr3113","volume":"14","author":"M Cizkova","year":"2012","unstructured":"Cizkova M, Susini A, Vacher S et al (2012) PIK3CA mutation impact on survival in breast cancer patients and in ERalpha, PR and ERBB2-based subgroups. Breast Cancer Res 14(1):R28","journal-title":"Breast Cancer Res"},{"key":"1377_CR36","unstructured":"http:\/\/cancer.sanger.ac.uk\/cosmic . Accessed 28 June 2018"},{"issue":"15","key":"1377_CR37","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1200\/JCO.2012.45.3605","volume":"31","author":"J Mendelsohn","year":"2013","unstructured":"Mendelsohn J (2013) Personalizing oncology: perspectives and prospects. J Clin Oncol 31(15):1904\u20131911","journal-title":"J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-018-1377-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1377-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T20:16:27Z","timestamp":1662754587000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-018-1377-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["1377"],"URL":"https:\/\/doi.org\/10.1007\/s10147-018-1377-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,5]]},"assertion":[{"value":"6 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}